ACE inhibitor development Flashcards
what is a structure activity relationship
the relationship between chemical structure and pharmacological activity for a series of compounds
what is the aim of a structure activity relationship
identify which functional groups are important for binding/activity
what is the method of a structure activity relationship
- alter, remove or mask a functional group
- test the analogue for activity
- conclusions depend on the method of testing
- in vitro- tests for binding interactions with target
- in vivo- tests for target binding interactions/pharmacokinetics
- if in vitro activity drops, it implies group is important for binding
- if in vivo activity is unaffected, it implies group is not important
what are quantitive structure activity relationships
mathematical relationships linking chemical structure and pharmacological activity in a quantitive manner for a series of compounds
what is a pharmacophore
structure that effectively binds to the specific therapeutic target to produce the desired effect by triggering or blocking its biological response
- serves as a template for the synthesis of analogues during optimisation
what is teprotide
a peptide from bothrops venom
- a potent, selective ACE inhibitor
what substrates for ACE are required by iteration
- a free carboxyl group on the C terminal
- that proline is not present in the penultimate- position to the C terminal
- a hydrophobic amino acid is present at the ante-penultimate position to the c terminal
describe the structure of teprotide
- has a free -COOH on C terminal
- pro is present in penultimate position
- hydrophobic aa (isoleucine) is present in ante-penultimate position
- is not a substrate ACE, it is an inhibitor
give examples of side effects of captopril (ACE inhibitor)
rash, loss of taste, metallic taste in mouth
why was a methyl group introduced in the development of carboxylate containing ACE inhibitors
methyl group introduced to counterbalance hydrophilicity of introduced nitrogen
define prodrug
a class of drugs, the pharmacologic action of which results from conversion by metabolic processes within the body (biotransformation)